Grifols, S.A. announced that on 3 January 2014 a $1.5 billion bridge loan has been signed and fully subscribed in equal parts by Nomura, BBVA and Morgan Stanley. The loan will be used for the payment related to the acquisition of the diagnostics business unit of the Swiss company Novartis International AG (Novartis) as informed in the Relevant Event dated 11th November 2013. The loan does not include any financial restrictions with respect to Grifols dividends policy or investments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.86 EUR | -1.38% |
|
-13.82% | -49.14% |
06-27 | European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading | MT |
06-27 | Grifols Shares Fall Premarket Following Downgrade by Moody's | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.14% | 5.15B | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.41% | 33.3B | |
+75.79% | 27.92B | |
-14.61% | 15.85B | |
-3.46% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- GRF Stock
- News Grifols, S.A.
- Grifols, S.A. Announces $1.5 Billion Bridge Loan